JPWO2023131920A5 - - Google Patents
Info
- Publication number
- JPWO2023131920A5 JPWO2023131920A5 JP2024541193A JP2024541193A JPWO2023131920A5 JP WO2023131920 A5 JPWO2023131920 A5 JP WO2023131920A5 JP 2024541193 A JP2024541193 A JP 2024541193A JP 2024541193 A JP2024541193 A JP 2024541193A JP WO2023131920 A5 JPWO2023131920 A5 JP WO2023131920A5
- Authority
- JP
- Japan
- Prior art keywords
- level
- pharmaceutical composition
- patient
- dynorphin
- identified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298047P | 2022-01-10 | 2022-01-10 | |
| US63/298,047 | 2022-01-10 | ||
| PCT/IB2023/050170 WO2023131920A1 (en) | 2022-01-10 | 2023-01-09 | Compositions and methods for the treatment of depression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025503646A JP2025503646A (ja) | 2025-02-04 |
| JP2025503646A5 JP2025503646A5 (https=) | 2026-01-16 |
| JPWO2023131920A5 true JPWO2023131920A5 (https=) | 2026-01-16 |
Family
ID=84981555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541193A Pending JP2025503646A (ja) | 2022-01-10 | 2023-01-09 | うつ病の治療のための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250221960A1 (https=) |
| EP (1) | EP4463152A1 (https=) |
| JP (1) | JP2025503646A (https=) |
| KR (1) | KR20240132479A (https=) |
| CN (1) | CN118510507A (https=) |
| AU (1) | AU2023205471A1 (https=) |
| CA (1) | CA3247760A1 (https=) |
| IL (1) | IL314179A (https=) |
| MX (1) | MX2024008618A (https=) |
| WO (1) | WO2023131920A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024336807A1 (en) * | 2023-09-06 | 2026-04-16 | Janssen Pharmaceuticals, Inc. | Compositions comprising aticaprant for use in treating major depressive disorder |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5345637B2 (ja) * | 2008-01-22 | 2013-11-20 | イーライ リリー アンド カンパニー | κ選択的オピオイド受容体アンタゴニスト |
-
2023
- 2023-01-09 MX MX2024008618A patent/MX2024008618A/es unknown
- 2023-01-09 IL IL314179A patent/IL314179A/en unknown
- 2023-01-09 CN CN202380016647.0A patent/CN118510507A/zh active Pending
- 2023-01-09 US US18/727,772 patent/US20250221960A1/en active Pending
- 2023-01-09 WO PCT/IB2023/050170 patent/WO2023131920A1/en not_active Ceased
- 2023-01-09 AU AU2023205471A patent/AU2023205471A1/en active Pending
- 2023-01-09 JP JP2024541193A patent/JP2025503646A/ja active Pending
- 2023-01-09 CA CA3247760A patent/CA3247760A1/en active Pending
- 2023-01-09 EP EP23700339.7A patent/EP4463152A1/en active Pending
- 2023-01-09 KR KR1020247026164A patent/KR20240132479A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Moldofsky et al. | A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy | |
| Pizzi et al. | Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease | |
| BG108379A (bg) | Използване на енантиомерно чист есциталопрам | |
| Giménez-Bastida et al. | Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts | |
| RU2760682C2 (ru) | Стабилизаторы тучных клеток лечения гиперцитокинемии и вирусной инфекции | |
| RU97119427A (ru) | Сочетание ингибитора усвоения 5-нт с селективным 5-нтia антагонистом | |
| JP2022191257A5 (https=) | ||
| Pollack | The pharmacotherapy of panic disorder | |
| JP2015526458A5 (https=) | ||
| MA52861B1 (fr) | Méthodes et compositions pour le traitement de l'apnée du sommeil ou le ronflement simple | |
| SE9501567D0 (sv) | A new combination | |
| AR047719A1 (es) | Procedimiento para el tratamiento de trastornos de depresion y ansiedad mediante terapia de combinacion que comprenden un ligando alfa-2-delta y un ssri y/o un snri | |
| JPWO2023054732A5 (https=) | ||
| JP2005502579A5 (https=) | ||
| TW201010695A (en) | Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack | |
| ATE491715T1 (de) | Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten | |
| JP2001510826A5 (https=) | ||
| Nowatzky et al. | Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis | |
| RU2008151516A (ru) | СПОСОБ УВЕЛИЧЕНИЯ БИОЛОГИЧЕСКОЙ АКТИВНОСТИ ОЧИЩЕННОГО БЕЛКА HspE7 | |
| JPWO2019212690A5 (https=) | ||
| JPWO2023131920A5 (https=) | ||
| IL315409A (en) | Polymorph forms of aticaprant for use in treating major depressive disorder | |
| RU2011131532A (ru) | Способ лечения бессонницы | |
| RU2024122065A (ru) | Композиции и способы лечения депрессии | |
| WO2003099226A3 (en) | Antibody peg positional isomers, compositions comprising same, and use thereof |